Clinical Trial Update: Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel [NA]

View source ↗

Summary

A completed clinical trial sponsored by Institut Curie evaluated plasma alcohol concentration in patients receiving paclitaxel or docetaxel for tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Taxol (paclitaxel)
• Taxotere (docetaxel)

Snippet

Sponsor: Institut Curie | Conditions: Tumors | NA | Status: COMPLETED